Conceptual Framework:A model derived from Hess and Insel’s (2007) Conceptual Model of Chemotherapy-Related Changes in Cognitive Function guided this analysis.
Methods:A secondary data analysis was completed on a cross-sectional, descriptive study of 68 BCS from a Midwestern cancer center. BCS completed questionnaires including the Pittsburgh Sleep Quality Index (PSQI), the Attentional Function Index (AFI), and demographic questionnaires. Sleep disturbance, a sub-scale of the PSQI, is measured by asking 9 questions about different sleep disturbances (i.e. dreams, temperature, pain, etc.) there occurrence and frequency. Higher sleep disturbance scores indicate worse sleep disturbance. Attentional fatigue was captured by using the AFI, a 13 question scale. Higher AFI scores indicate higher functioning. Descriptive statistics and multiple regression was performed to assess the impact of sleep disturbance on attentional fatigue controlling for the covariates of age, level of education, and time since treatment.
Results:68 female BCS, ranging from 29 to 68 years of age (M=52.1; SD=8.6) and on average 4.97 (SD=3.36) years post-treatment, participated. In this sample 31% of the BCS had moderate to poor attentional function. Sleep disturbance significantly predicted attentional fatigue (p<0.05), explaining 16% of the variance of attentional fatigue, F(4, 57) = 2.68, p < 0.04, R2 = 0.16. Age, level of education, and time since treatment did not significantly predict attentional fatigue.
Conclusions:Nurses are in a position to assess and intervene to decrease sleep disturbance and improve attentional fatigue in BCS. However, sleep disturbance is just one factor contributing to attentional fatigue. Further investigation into other factors contributing to attentional fatigue in BCS is warranted.
See more of: Invited Posters